Showing results (321-330 of 1,536) with videos related to

Sort By:
Pageof 154
Travel Medicine and Infectious Disease|October 13, 2025
Clinical application value of droplet digital PCR detection of Em-cfDNA in the diagnosis of hepatic alveolar echinococcosisYuan Jiang, Lingqiang Zhang, Yaogang Zhang, et al.
Travel Medicine and Infectious Disease|October 3, 2025
Clinical features and outcomes of dengue and scrub typhus in hospitalized adults in the MaldivesRajib Kumar Dey, Fernando Mosler, Rifau Adam, et al.
Travel Medicine and Infectious Disease|June 23, 2020
Measles immunity gaps in an era of high vaccination coverage: A serology study from TaiwanYi-Chen Lee, Yi-Hsuan Lee, Chia-Wen Lu, et al.
Travel Medicine and Infectious Disease|April 25, 2020
Schistosoma serology after praziquantel treatment of Schistosoma infection in refugee children resettled in Australia: A retrospective analysisThomas Volkman, Vanessa Clifford, Georgia A Paxton
Travel Medicine and Infectious Disease|April 23, 2020
Increase in cases of dengue in China, 2004-2016: A retrospective observational studyHui Zhang, Khalid Mehmood, Yung-Fu Chang, et al.
Travel Medicine and Infectious Disease|September 20, 2025
Extended Lake Louise Score: a novel standard evaluation of cognitive impairment for immigrants' rapid ascent to high altitudeTao Xu, Wen Li, Chun-Yan Zhang, et al.
Travel Medicine and Infectious Disease|August 8, 2025
An imported case of Haplorchis taichui infection diagnosed with molecular genomics in FranceVictor Luzarraga, Maxime Moniot, Patricia Combes, et al.
Travel Medicine and Infectious Disease|July 30, 2025
Measles importations by international travelers, GeoSentinel 2019-2025Ralph Huits, Dora Buonfrate, Kevin O'Laughlin, et al.
Travel Medicine and Infectious Disease|July 25, 2025
Chagas disease induces gut microbial metabolic stress: Disruption of energy and nucleotide pathways and partial reversal by antiparasitic therapy (TRIPOBIOME-2 study)José A Pérez-Molina, Elena Moreno, Clara Crespillo-Andújar, et al.
Travel Medicine and Infectious Disease|December 22, 2024
The safety, pharmacokinetics and neutralizing activity of recombinant human anti-rabies monoclonal antibody NM57 injection (rhRIG, Ormutivimab) in combination with rabies vaccination in Chinese healthy adults: A phase Ib randomized, double-blind, parallel-controlled clinical studyYin Yin, Min Jia, Yufeng Li, et al.
Pageof 154